U-M researchers identify a potential treatment for non-alcoholic fatty liver disease.
Forty percent of people who develop venous thromboembolism don’t know what caused it. New research in mice further explores inflammation’s role.
Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.
A 600-patient randomized clinical trial supports pembrolizumab and chemotherapy as a first-line treatment
The largest study of its kind finds societal factors and access to quality care, rather than genetics, underlies higher prostate cancer mortality rates for black men.
New research shows that a combination of two immune-system factors could open up new avenues for treating diabetes and obesity.